project id: TCGA-STAD; case submitter id: TCGA-B7-A5TJ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.45; rna integrity number: 7.0; age at index: 74; days to birth: -27057; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1938; age at diagnosis: 27057; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 335.0; icd 10 code: C16.1; last known disease status: not reported; morphology: 8144/3; primary diagnosis: Adenocarcinoma, intestinal type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Fundus of stomach; synchronous malignancy: No; tissue or organ of origin: Fundus of stomach; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 42; initial weight: 150.0; sample id: fc264b14-c3ce-4a94-b9e5-205abeec9cab; sample submitter id: TCGA-B7-A5TJ-01A; portion id: d1f61e96-81cf-4dd9-b7c8-d16e7b2bfe91; portion submitter id: TCGA-B7-A5TJ-01A-11; slide id: 240e90b5-5092-4c57-9b22-ad9f9bbdf727; slide submitter id: TCGA-B7-A5TJ-01A-01-TSA; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 4.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 61.0; percent tumor cells: 35.0; percent tumor nuclei: 70.0; section location: TOP;